The applicants are entities that own pharmacies and applying for leave to appeal against the validity of the Regulations relating to a Transparent Pricing System for Medicines and Scheduled Substances. The major issues in question are whether the fees were appropriate and the regulation of the single exit price was legal. Leave to appeal was granted and the first respondent was ordered to pay the costs including the costs of two counsel.